POS-223 Clinical Utility of KidneyIntelX in Patients with Early Stages of Diabetic Kidney Disease in CANVAS Participants
Main Authors: | D. Lam, G. Nadkarni, B. Neal, K. Mahaffey, N. Rosenthal, M. Hansen, S. COCA, H. Heerspink |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024921003831 |
Similar Items
-
The Non-coding MicroRNA-223 is a Promising Biomarker of Chronic Kidney Disease
by: Valérie Metzinger-Le Meuth, et al.
Published: (2021-07-01) -
Liver function markers predict cardiovascular and renal outcomes in the CANVAS Program
by: Ferrannini, E., et al.
Published: (2022) -
Canva
by: Alison Paige Gehred
Published: (2020-04-01) -
POS-327 THE COST OF END OF LIFE INPATIENT ENCOUNTERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN THE UNITED STATES
by: M. ARNOLD, et al.
Published: (2021-04-01) -
POS-735 NSAID PRESCRIPTIONS IN KIDNEY TRANSPLANT RECIPIENTS
by: R. JEONG, et al.
Published: (2021-04-01)